Actu / event2019-01-07T17:46:08+00:00

Nos actualités et évènements

Pour aller plus loin …

  • Calyxt Doubles 2018 High Oleic Soybean Acres 22 janvier 2019
    Tuesday, January 22nd 2019 at 10:30pm UTC Surpasses 34,000 acres of High Oleic Soybean contracted for 2019 growing season MINNEAPOLIS & ST. PAUL, Minn.–(BUSINESS WIRE)– Calyxt, Inc. (NASDAQ: CLXT) a consumer-centric, food- and agriculture-focused company, announced today that it has contracted over 34,000 acres of its High Oleic Soybean with more than 100 farmers in […]
    Rédaction
  • Revance Announces Closing of Public Offering of Common Stock 22 janvier 2019
    Tuesday, January 22nd 2019 at 9:05pm UTC Gross Proceeds of Offering Total 115.0 Million NEWARK, Calif.–(BUSINESS WIRE)– Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic and therapeutic conditions (“Revance” or the “Company”), today announced the closing of an underwritten public offering of 6,764,705 shares of its common […]
    Rédaction
  • UroGen Pharma Announces Proposed Public Offering of Ordinary Shares 22 janvier 2019
    Tuesday, January 22nd 2019 at 9:01pm UTC NEW YORK–(BUSINESS WIRE)– UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced that it intends to offer and sell $150 million of its ordinary shares in an underwritten public offering. The […]
    Rédaction
  • Gilead Sciences to Release Fourth Quarter and Full Year 2018 Financial Results on Monday, February 4, 2019 22 janvier 2019
    Tuesday, January 22nd 2019 at 9:05pm UTC — Conference Call and Webcast to Follow — FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2018 financial results will be released on Monday, February 4, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will […]
    Rédaction
  • Vertex to Announce Full-Year and Fourth-Quarter 2018 Financial Results on February 5 22 janvier 2019
    Tuesday, January 22nd 2019 at 9:01pm UTC BOSTON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its full year and fourth quarter 2018 financial results on Tuesday, February 5, 2019 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (866) […]
    Rédaction
  • BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2019 22 janvier 2019
    Tuesday, January 22nd 2019 at 5:26pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– BIOQUAL, Inc. (OTC Pink: BIOQ) (www.bioqual.com):     Six Months EndedNovember 30, Three Months EndedNovember 30, 2018   2017 2018   2017   Revenue $ 18,014,347 $ 17,800,956 $ 8,361,478 $ 9,096,203   Income Before Income Tax $ 1,698,986 $ 2,621,662 $ 811,813 $ 1,259,364 […]
    Rédaction
  • Oxford Nanopore Prevails in Patent Ruling against Pacific Biosciences 22 janvier 2019
    Tuesday, January 22nd 2019 at 5:04pm UTC OXFORD, England–(BUSINESS WIRE)– Today the European Patent Office revoked Pacific Biosciences patent EP3045542 with claims to a single molecule sequencing process wherein two strands of DNA are linked by a connecting nucleic acid. The validity of the patent had been challenged by Oxford Nanopore. The EPO ruled that […]
    Rédaction
  • Aether and UCL Researchers Democratizing 3D Printed Nanotech at 2% of Competitor Cost 22 janvier 2019
    Tuesday, January 22nd 2019 at 5:00pm UTC SAN FRANCISCO–(BUSINESS WIRE)– Aether, the pioneer of AI enhanced 3D bioprinting, has announced a collaboration with researchers from University College London (“UCL”) and Loughborough University to develop a powerful new approach to 3D printing nanotechnology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190122005388/en/ (Photo: Business […]
    Rédaction
  • Flow Cytometry Market, 2023 – Growing Focus on Immunology and Immuno-Oncology Research – ResearchAndMarkets.com 22 janvier 2019
    Tuesday, January 22nd 2019 at 4:53pm UTC DUBLIN–(BUSINESS WIRE)– The « Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents & Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Labs, Pharma-Biotech), Application, Region – Global Forecast to 2023 » report has been added to ResearchAndMarkets.com’s offering. The global flow cytometry market is projected to […]
    Rédaction
  • Global qPCR and dPCR Market Outlook to 2023 – Growth Opportunities, Competitive Dynamics, Regional Assessment, as Well as Novel Business Models – ResearchAndMarkets.com 22 janvier 2019
    Tuesday, January 22nd 2019 at 4:08pm UTC DUBLIN–(BUSINESS WIRE)– The « Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023 » report has been added to ResearchAndMarkets.com’s offering. This study highlights the prominence of qPCR and dPCR globally, growth opportunities, competitive dynamics, regional assessment, as well as novel business models. PCR continues to be […]
    Rédaction

Discutons
de votre projet !

Que vous ayez un projet concret à booster ou besoin de conseils pour valider votre réflexion stratégique ou opérationnelle, nous sommes à votre écoute pour en discuter.

Contactez-nous !

Articles récents

Contact Info

6, rue Alfred de Musset - 94800 Villejuif

Phone: +33 9 86 56 14 74

Mobile: +33 6 85 67 46 91